Intersect ENT prices its initial public offering at $11 per share, the low end of its predicted range, hoping to raise $55 million when XENT shares hit the NASDAQ exchange today.
Intersect ENT said today that it's shares should hit the NASDAQ exchange at $11 apiece, the low end of the range, for expected proceeds of $55 million.
At that price, Intersect would command a market capitalization of roughly $267 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1x6NrAN
Cap comentari:
Publica un comentari a l'entrada